• All abstract submissions and presentations must be in English.
• European Congress registration is required for all presenters.
• Expenses associated with submissions and presentations are the responsibility of the presenter.
• Case study abstracts should be no longer than 750 words.
• The use of tables and graphs in your abstract submission is not allowed.

CASE STUDY SUBMISSION INFORMATION

GENERAL INFORMATION

• Case Study abstracts from health care decision makers are designed to describe situations where organizations attempted to integrate cost and outcome information into their processes and procedures for pharmaceuticals, devices, or medical procedures. ISPOR encourages submissions describing successes, works in progress, or failures in this domain.
• The case study should include issues involved in the process or decision including the usefulness or non-usefulness of the outcomes research information, and recommendations, if appropriate, on the outcomes research information regarding information transparency, completeness of data, format or presentation of information.
  
• The primary author of a case study abstract must be a health care decision-maker. Co-authors can include any individual involved in the case study.

POSSIBLE TOPICS FOR CASE STUDY ABSTRACTS

Topics for case study abstracts may include but are not limited to:

• Attempts to introduce cost or cost-effectiveness information into formulary decision making processes of Pharmacy and Therapeutics committees.
• Pay for performance programs that focus on patient oriented outcomes or reducing health care expenditures.
• Initiatives to measure patient reported outcomes as part of clinical quality improvement initiatives.
• Purchasing or contracting negotiations with manufacturers that involve cost-effectiveness or outcomes measures as opposed to product prices.

Case Study Abstract Example